Badiaga - (2x-30ch) Tab 2 X Tablet is a Health Canada–registered human drug (DIN 02108305) held by Homeocan Inc., containing Badiaga. Health Canada lists its status as Cancelled Post Market (status date 12 Feb 1998). Nexara Health has matched 9 registrations of Badiaga across 2 other regulated markets.
Health Canada registration
| DIN | 02108305 |
|---|---|
| Brand name | Badiaga - (2x-30ch) Tab |
| Active ingredient | Badiaga |
| Strength | 2 X |
| Dosage form | Tablet |
| Route | Oral |
| Company | Homeocan Inc. |
| Status | Cancelled Post Market — 12 Feb 1998 |
| Class | Human |
| ATC | |
| AHFS | 92:02.00* ; See footnote |
| Regulator record | Health Canada DPD entry · Product monograph |
Badiaga registered in other markets
9 registrations of the same molecule in 2 national registries outside Canada. Each row is taken from the regulator's own published list; status is shown as the registry reports it.
| Country | Product | Marketing authorisation holder | Strength | Form | Status | Registry |
|---|---|---|---|---|---|---|
| Netherlands | Badiaga | BOIRON (Messimy) | 8 DH t/m 60 DH#4 CH t/m 200 CH#7 K t/m 100.000K# | Uitsluitend apotheek of drogist | EU national register | |
| Netherlands | Badiaga | BOIRON (Messimy) | 8 DH t/m 60 DH#4 CH t/m 200 CH#7 K t/m 100.000K# | Globuli | Uitsluitend apotheek of drogist | EU national register |
| United States | Badiaga | Hahnemann Laboratories, Inc. | Pellet | listed | FDA NDC | |
| United States | Badiaga | Hahnemann Laboratories, Inc. | Pellet | listed | FDA NDC | |
| United States | Badiaga | Hahnemann Laboratories, Inc. | Pellet | listed | FDA NDC | |
| United States | Badiaga | Hahnemann Laboratories, Inc. | Pellet | listed | FDA NDC | |
| United States | Badiaga | Hahnemann Laboratories, Inc. | Pellet | listed | FDA NDC | |
| United States | Badiaga | Hahnemann Laboratories, Inc. | Pellet | listed | FDA NDC | |
| United States | Badiaga | Hahnemann Laboratories, Inc. | Pellet | listed | FDA NDC |
See every manufacturer of Badiaga worldwide →
Sourcing through Nexara Health
Nexara Health is a Health Canada–licensed wholesaler (DEL #3-002896) in Winnipeg. This DIN is not currently marketed in Canada. The registrations above show which regulated markets hold an equivalent presentation that can be sourced for clinical comparator use or on a named-patient basis under Health Canada's Special Access Programme. Request a quote or read how named-patient and foreign-pack supply works in Canada.
Frequently asked questions
Is Badiaga - (2x-30ch) Tab (DIN 02108305) marketed in Canada?
No. Health Canada lists DIN 02108305 as Cancelled Post Market as of 12 Feb 1998.
Who holds the Canadian licence for this product?
Homeocan Inc. is the company of record in the Health Canada Drug Product Database.
Is Badiaga registered outside Canada?
Yes — Nexara Health has matched 9 registrations in 2 other markets (see the table above).
Where does this data come from?
Health Canada Drug Product Database (DPD), DIN 02108305, status date 1998-02-12; national medicine registries: EU national register, FDA NDC. Nexara Health re-checks these sources weekly and shows the last verification date at the top of the page.
Source: Health Canada Drug Product Database (DPD), DIN 02108305, status date 1998-02-12; national medicine registries: EU national register, FDA NDC.
Health Canada Drug Product Database (DPD), DIN 02108305, status date 1998-02-12; national medicine registries: EU national register, FDA NDC. Last reviewed 2026-09-16. Nexara Health is a licensed wholesaler and supplies licensed entities only; consumer orders are routed to a partner pharmacy.